about
Mechanisms of altered Ca²⁺ handling in heart failureGene therapy targets in heart failure: the path to translationExtracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performanceImpaired cardiac contractility response to hemodynamic stress in S100A1-deficient miceS100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4S100A1 in human heart failure: lack of recovery following left ventricular assist device supportCardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal modelS100A1 and calmodulin regulation of ryanodine receptor in striated muscleS100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapyTargeting S100A1 in heart failureS100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction couplingS100A1: Structure, Function, and Therapeutic PotentialS100A1 enhances the L-type Ca2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytesS100A1: a multifaceted therapeutic target in cardiovascular diseaseCardiac adenoviral S100A1 gene delivery rescues failing myocardiumMicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1Augmentation of Cav1 channel current and action potential duration after uptake of S100A1 in sympathetic ganglion neurons.The inotropic peptide βARKct improves βAR responsiveness in normal and failing cardiomyocytes through G(βγ)-mediated L-type calcium current disinhibition.Differential effects of S100 proteins A2 and A6 on cardiac Ca(2+) cycling and contractile performance.A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics.S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial functionInterplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.Spatiotemporal expression of matrix metalloproteinases (MMPs) is regulated by the Ca2+-signal transducer S100A4 in the pathogenesis of thoracic aortic aneurysm.Differential gene expression in ovarian carcinoma: identification of potential biomarkersS100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers.Gene delivery approaches to heart failure treatment.Bioactive nanoparticles improve calcium handling in failing cardiac myocytes.Liquid jet delivery method featuring S100A1 gene therapy in the rodent model following acute myocardial infarction.Gene transfer for congestive heart failure: update 2013.S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.Regulation of Na+/Ca2+ exchange current in the normal and failing heart.S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance.Gene therapy in heart failure.Influence of doxazosin on biosynthesis of S100A6 and atrial natriuretic factor peptides in the heart of spontaneously hypertensive ratsS100A1 transgenic treatment of acute heart failure causes proteomic changes in rats.Designing heart performance by gene transfer.Gene therapy to treat cardiovascular disease.Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.
P2860
Q27012758-F4544929-B13A-47FF-9E6D-6D6E398B9375Q27022444-8918605D-0488-47A8-9FD5-62DFA96F005BQ28205358-A401E903-2D97-4FE8-84BE-155297A71C37Q28207738-1E3CEEA4-C526-4D5E-B454-DB603EA5C209Q28209366-78EA92EC-C6F2-45A9-8566-28B56CEB0BBFQ28240188-A8695ECA-20D6-46CF-AF7B-8730E01E1C5BQ28240412-FCCB02BE-5D12-4436-857E-D8EF4A9F9E32Q28243737-B0D3FF18-3C2A-488C-A25F-926B330699FDQ28243947-4277B93F-155C-4790-A909-76F632FEB9A3Q28245847-3193AB88-997C-4BEE-9EA7-03DA5B6622F0Q28249115-3D3DF939-8385-4420-B6B7-529DF96A17C3Q28259868-9A989112-7D7C-45AA-BAA5-251707327943Q28261526-2844AF07-1198-4F24-917E-56AA6BF86BE7Q28263662-4EB0F672-D2ED-4FC1-BEA9-EB22DD1C0E53Q28269629-8E2288AB-499C-45CF-B734-2484BD06E1CDQ28288362-DCA16A9D-B40F-4A90-899A-2309991417A0Q28296403-56FFB84E-FC87-49BC-9F53-A4A356F1CF7AQ28534986-C34730F6-2DA6-4EE2-8879-8D308A9C51DBQ28580012-25E51106-FC23-4FE9-8F85-A6E420537951Q30577637-72098C0A-8D09-4A51-9255-82284CA09ABAQ30579578-22DEAFC0-AFBE-44A2-B1BB-D51ADCACFE97Q33312065-C17133EA-1148-4620-B2C4-16E7938F6456Q33757903-AF8905A2-0BB2-4CC7-89EA-F218D43DFDEAQ34184312-57644255-2774-4247-85B8-CB058EEC84D3Q34905545-AABF3B63-9319-4270-94FE-28D37C2914F9Q35103006-C1ACEB00-301B-4A02-9661-7FADC92FDCA8Q35872865-9A8AD693-1C9F-4F7A-ABD7-CB5340E44A23Q35873759-63682A10-B2EB-46FF-BCF8-59DB85AEA4A7Q36421703-B10F89C3-903D-4C84-9FB6-2E60D09CE7B0Q36547398-1B02CF11-90F9-4ECA-94D1-69B60AF9E240Q36698991-F832FD57-D67F-4B75-A99F-C66A39EE0F78Q36756998-D192DA66-903F-40AD-B3D7-CAA8F41A1DF9Q36796667-064C8689-5996-4339-9113-9E7BA2B16C17Q36801998-1F04481C-92ED-459C-BFAA-E60CF2EB77FBQ36944623-61068724-4A75-4242-ADFC-D8FB0B8FA92EQ37071624-9365B68A-4174-4330-97A8-CB2B1845CD33Q37082922-6213E7EB-1296-4B4A-8472-6382B972385AQ37299072-664242DB-671B-44E2-B010-71289E152FABQ37310450-BEA9DACC-2599-456F-ABA9-4A35684B42EBQ38025012-DEF6D4DA-64A4-4142-A67A-E307BA7AF7A7
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
S100A1: a regulator of myocardial contractility
@ast
S100A1: a regulator of myocardial contractility
@en
S100A1: a regulator of myocardial contractility
@nl
type
label
S100A1: a regulator of myocardial contractility
@ast
S100A1: a regulator of myocardial contractility
@en
S100A1: a regulator of myocardial contractility
@nl
prefLabel
S100A1: a regulator of myocardial contractility
@ast
S100A1: a regulator of myocardial contractility
@en
S100A1: a regulator of myocardial contractility
@nl
P2093
P2860
P3181
P356
P1476
S100A1: a regulator of myocardial contractility
@en
P2093
F Niroomand
J Bernotat
P Ehlermann
P Karczewski
P2860
P304
13889-13894
P3181
P356
10.1073/PNAS.241393598
P407
P577
2001-11-01T00:00:00Z